潘特拉辛3缺乏症在2型低喘中加剧了中性恋炎症和气道过敏反应
Sina Taefehshokr1, Lianyu Shan1, Mojdeh Matloubi1
1Department of Immunology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Frontiers in allergy
|February 23, 2026
概括
潘特拉辛-3 (PTX3) 缺乏会加剧中性友炎症和过敏反应在小鼠模型的2型低喘. 这表明PTX3起着保护作用,可能是严重喘的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 生物化学 生物化学
背景情况:
- 2型低喘是一种严重的,耐固醇喘表型,以中性友炎症为标志.
- 潘特拉辛-3 (PTX3) 是一种天生的免疫蛋白,在2型低喘中没有明确的作用.
研究的目的:
- 为了研究PTX3在2型低喘的小鼠模型中的作用.
主要方法:
- 一种慢性室内灰尘虫 (HDM) 加上循环di-GMP小鼠模型被用于模拟2型低喘.
- 肺炎,细胞因子概况,抗体反应和肺功能 (AHR) 在PTX3淘汰赛 (PTX3-/-) 和野生型 (WT) 小鼠中进行了评估.
主要成果:
- 在PTX3-/-小鼠中,呼吸道炎症增加,中性粒细胞数量增加,IL-17A水平升高.
- 由于PTX3缺乏,导致总和HDM特异性IgE增加,气道过敏反应 (AHR) 显著增加.
- 乙氨基细胞数量和关键的2型细胞因子 (IL-4,IL-5,IL-13) 保持不变.
结论:
- 在2型低喘中,PTX3缺失会恶化中性友炎症,IL-17A产生,IgE反应和AHR.
- PTX3成为2型低喘的潜在生物标志物和治疗标.
更多相关视频
相关概念视频
Asthma-II: Pathophysiology and Classification
4.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.0K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K
Antiasthma Drugs: Leukotriene Modifiers
2.0K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.9K
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K


